Exploring the effect of biological delays in kinetic models of influenza within a host or cell culture

BMC Public Health

Volumn 11, Issue SUPPL. 1, 2011, Pages

  Holder, Benjamin P ^a   Beauchemin, Catherine A A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOLOGICAL MODEL; CULTURE TECHNIQUE; DISEASE TRANSMISSION; HUMAN; INFLUENZA; KINETICS;

CELL CULTURE TECHNIQUES; HUMANS; INFLUENZA, HUMAN; KINETICS; MODELS, BIOLOGICAL;

EID: 79952556014     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-S1-S10     Document Type: Article

References (62)

1. Lenglet AD, Hernando V, Rodrigo P, Larrauri A, Donado JD, de Mateo S: Impact of flu on hospital admissions during 4 flu seasons in Spain, 2000-2004. BMC Public Health 2007, 7:197.
2. Möhler L, Flockerzi D, Sann H, Reichl U: Mathematical model of influenza A virus production in large-scale microcarrier culture. Biotechnol. Bioeng 2005, 90:46-58. (Pubitemid 40547038)
3. Beauchemin C, McSharry J, Drusano G, Nguyen J, Went G, Ribeiro R, Perelson A: Modeling amantadine treatment of influenza A virus in vitro. J. Theor. Biol 2008, 254:439-451.
4. Baccam P, Beauchemin C, Macken C, Hayden F, Perelson A: Kinetics of influenza A virus infection in humans. J. Virol 2006, 80:7590-7599. (Pubitemid 44092580)
5. Handel A, Longini I, Antia R: Towards a quantitative understanding of the within-host dynamics of influenza A infections. J. R. Soc. Interface 2010, 7:35-47.
6. Ho D, Neumann A, Perelson A, Chen W, Leonard J, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
7. Smith AM, Ribeiro RM: Modeling the viral dynamics of influenza a virus infection. Crit. Rev. Immunol 2010, 30:291-298.
8. Dulbecco R, Vogt M: Plaque formation and isolation of pure lines with poliomyelitis viruses. J. Exp. Med 1954, 99:167-182.
9. Gaush C, Smith T: Replication and plaque assay of influenza virus in an established line of canine kidney cells. Appl. Environ. Microbiol 1968, 16:588-594.
10. Kermack W, McKendrick A: Contributions to the mathematical theory of epidemics, Part I. Proc. Roy. Soc. A 1927, 115:700-721.
11. Hethcote H, Tudor D: Integral equation models for endemic infectious diseases. J. Math. Biol 1980, 9:37-47. (Pubitemid 10116366)
12. Feng Z, Xu D, Zhao H: Epidemiological models with non-exponentially distributed disease stages and applications to disease control. Bull. Math. Biol 2007, 69:1511-1536.
13. Wearing HJ, Rohani P, Keeling MJ: Appropriate models for the management of infectious diseases. PLoS Med 2005, 2:0621-0627. (Pubitemid 46179273)
14. Lloyd AL: Destabilization of epidemic models with the inclusion of realistic distributions of infectious periods. Proc. R. Soc. Lond., B, Biol. Sci 2001, 268:985-993.
15. Banks H, Bortz DM, Holte SE: Incorporation of variability into the modeling of viral delays in HIV infection dynamics. Math. Biosci 2003, 183:63-91. (Pubitemid 36343663)
16. Lakadamyali M, Rust MJ, Babcock HP, Zhuang X: Visualizing infection of individual influenza viruses. Proc. Natl. Acad. Sci. U.S.A 2003, 100:9280-9285.
17. Martin K, Helenius A: Nuclear transport of influenza virus ribonucleoproteins: The viral matrix protein (M1) promotes export and inhibits import. Cell 1991, 67:117-130.
18. Nayak DP, Hui EKW, Barman S: Assembly and budding of influenza virus. Virus Res 2004, 106:147-165. (Pubitemid 39572961)
19. Takizawa T, Matsukawa S, Higuchi Y, Nakamura S, Nakanishi Y, Fukuda R: Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J. Gen. Virol 1993, 74:2347-2355. (Pubitemid 23332295)
20. Zhirnov O, Klenk HD: Human influenza A viruses are proteolytically activated and do not induce apoptosis in CACO-2 cells. Virology 2003, 313:198-212. (Pubitemid 37013604)
21. Mohsin MA, Morris SJ, Smith H, Sweet C: Correlation between levels of apoptosis, levels of infection and haemagglutinin receptor binding interaction of various subtypes of influenza virus: Does the viral neuraminidase have a role in these associations. Virus Res 2002, 85:123-131. (Pubitemid 34606907)
22. Lee HY, Topham DJ, Park SY, Hollenbaugh J, Treanor J, Mosmann TR, Jin X, Ward BM, Miao H, Holden-Wiltse J, Perelson AS, Zand M, Wu H: Simulation and prediction of the adaptive immune response to influenza A virus infection. J. Virol 2009, 83:7151-7165.
23. Mittler JE, Sulzer B, Neumann AU, Perelson AS: Influence of delayed viral production on viral dynamics in HIV-1 infected patients. Math. Biosci 1998, 152:143-163. (Pubitemid 28450733)
24. Grossman Z, Feinberg M, Kuznetsov V, Dimitrov D, Paul W: HIV infection: How effective is drug combination treatment? Immunol. Today 1998, 19:528-532. (Pubitemid 28518033)
25. Lloyd AL: Dependence of viral parameter estimates on the assumed viral life cycle: Limitations of studies of viral load data. Proc. R. Soc. Lond., B, Biol. Sci 2001, 268:847-854.
26. Keele BF, Learn HLGH, Hraber P, Giorgi EE, Grayson T, Sun C, Chen Y, Yeh WW, Letvin NL, Mascola JR, Nabel GJ, Haynes BF, Bhattacharya T, Perelson AS, Korber BT, Hahn BH, Shaw GM: Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. J. Exp. Med 2009, 206:51117-51134.
27. Zwart MP, Hemerik L, Cory JS, de Visser JAG, Bianchi FJ, Oers MMV, Vlak JM, Hoekstra RF, der Werf WV: An experimental test of the independent action hypothesis in virus-insect pathosystems. Proc. R. Soc. Lond., B, Biol. Sci 2009, 276:2233-2242.
28. Hale B, Knebel A, Botting C, Galloway C, Precious B, Jackson D, Elliott R, Randall R: CDK/ERK-mediated phosphorylation of the human influenza A virus NS1 protein at threonine-215. Virology 2009, 383:6-11.
29. Min J, Krug R: The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2-5oligo(A) synthetase/RNase L pathway. Proc. Natl. Acad. Sci. U.S.A 2006, 103:7100-7105.
30. Nagai T, Moriguchi R, Suzuki Y, Tomimori T, Yamada H: Mode of action of the anti-influenza virus activity of plant flavonoid, 5,7,4-trihydroxy-8- methoxyflavone, from the roots of Scutellaria baicalensis. Antiviral Res 1995, 26:11-25.
31. Kaverin N, Webster R: Impairment of multicycle influenza virus growth in Vero (WHO) cells by loss of trypsin activity. J. Virol 1995, 69:2700-2703.
32. Sugiura A, Kilbourne E: Genetic studies of influenza viruses II. Plaque formation by influenza viruses in a clone of a variant human heteroploid cell line. Virology 1965, 26:478.
33. Holder BP, Liao LE, Simon P, Boivin G, Beauchemin CA: Design considerations in building in silico equivalents of common experimental influenza virus assays. Autoimmunity 2011.
34. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron AJ: Time lines of infection and disease in human influenza: A review of volunteer challenge studies. Am. J. Epidemiol 2008, 167:775-785. (Pubitemid 351451744)
35. Xia X, Moog C: Identifiability of nonlinear systems with application to HIV/AIDS models. IEEE Trans. Automat. Contr 2003, 48:330-336.
36. Wu H, Zhu H, Miao H, Perelson A: Parameter identifiability and estimation of HIV/AIDS dynamic models. Bull. Math. Biol 2008, 70:785-799.
37. Miao H, Xia X, Perelson A, Wu H: On identifiability of nonlinear ODE models and applications in viral dynamics. SIAM Review 2011, To Appear.
38. Barroso L, Treanor J, Gubareva L, Hayden FG: Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: Randomized, controlled trials for prophylaxis and treatment. Antivir. Ther 2005, 10:901-910.
39. Bjornson A, Mellencamp M, Schiff G: Complement is activated in the upper respiratory tract during influenza virus infection. Am. Rev. Respir. Dis 1991, 143:1062-1066.
40. Nowak M, Bonhoeffer S, Hill A, Bohme R, Thomas H, McDade H: Viral dynamics in hepatitis B infection. Proc. Natl. Acad. Sci. U.S.A 1996, 93:4398-4404.
41. Sidorenko Y, Reichl U: Structured model of influenza virus replication in MDCK cells. Biotechnol. Bioeng 2004, 88:1-14. (Pubitemid 39388688)
42. Perelson A, Neumann A, Markowitz M, Leonard J, Ho D: HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science 1996, 271:1582-1586. (Pubitemid 26097216)
43. Ciupe SM, Ribeiro RM, Nelson PW, Dusheiko G, Perelson AS: The role of cells refractory to productive infection in acute hepatitis B viral dynamics. Proc. Natl. Acad. Sci. U.S.A 2007, 104:5050-5055.
44. Bauer AL, Beauchemin CA, Perelson AS: Agent-based modeling of hostpathogen systems: The successes and challenges. Inf. Sci. (Ny) 2009, 179:1379-1389.
45. Forrest S, Beauchemin CA: Computer immunology. Immunol. Rev 2007, 216:176-197. (Pubitemid 46426519)
46. Chavali AK, Gianchandani EP, Tung KS, Lawrence MB, Peirce SM, Papi JA: Characterizing emergent properties of immunological systems with multi-cellular rule-based computational modeling. Trends Immunol 2008, 29:589-599.
47. Sidorenko Y, Schulze-Horsel J, Voigt A, Reichl U, Kienle A: Stochastic population balance modeling of influenza virus replication in vaccine production processes. Chem. Eng. Sci 2008, 63:157-169.
48. Price G, Smith H, Sweet C: Differential induction of cytotoxicity and apoptosis by influenza virus strains of differing virulence. J. Gen. Virol 1997, 78:2821-2829. (Pubitemid 27480821)
49. Seo SH, Goloubeva O, Webby R, Webster RG: Characterization of a porcine lung epithelial cell line suitable for influenza virus studies. J. Virol 2001, 75:9517-9525. (Pubitemid 32851954)
50. Arndt U, Wennemuth G, Barth P, Nain M, Al-Abed Y, Meinhardt A, Gemsa D, Bacher M: Release of macrophage migration inhibitory factor and CXCL8/interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection. J. Virol 2002, 76:9298-9306. (Pubitemid 34919888)
51. Mori I, Komatsu T, Takeuchi K, Nakakuki K, Sudo M, Kimura Y: In vivo induction of apoptosis by influenza virus. J. Gen. Virol 1995, 76:2869-2873.
52. Ito T, Kobayashi Y, Morita T, Horimoto T, Kawaoka Y: Virulent influenza A viruses induce apoptosis in chickens. Virus Res 2002, 84:27-35. (Pubitemid 34251193)
53. Uiprasertkul M, Kitphati R, Puthavathana P, Kriwong R, Kongchanagul A, Ungchusak K, Angkasekwinai S, Chokephaibulkit K, Srisook K, Vanprapar N, Auewarakul P: Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans. 2007, 13:708-712.
54. Saenz RA, Quinlivan M, Elton D, MacRae S, Blunden AS, Mumford JA, Daly JM, Digard P, Cullinane A, Grenfell BT, McCauley JW, Wood JLN, Gog JR: Dynamics of infection and pathology in influenza. J. Virol 2010, 84:3974-3983.
55. Miao H, Hollenbaugh JA, Zand MS, Holden-Wiltse J, Mosmann TR, Perelson AS, Wu H, Topham DJ: Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus. J. Virol 2010, 84:6687-6698.
56. Doceul V, Hollinshead M, van der Linden L, Smith G: Repulsion of superinfecting virions: A mechanism for rapid virus spread. Science 2010, 327:873-876.
57. Bellman R, Åström K: On structural identifiability. Math Biosci 1970, 7:329-339.
58. Cobelli C, III JJD: Parameter and structural identifiability concepts and ambiguities: a critical review and analysis. Am. J. Physiol. Regulatory Integrative Comp. Physiol 1980, 239:R7-R24.
59. Bellu G, Saccomania MP, Audoly S, D'Angió L: DAISY: A new software tool to test global identifiability of biological and physiological systems. Comput. Methods Programs Biomed 2007, 88:52-61. (Pubitemid 47331951)
60. Eaton JW: GNU Octave. 2010 [http://www.octave.org].
61. Burnham KP, Anderson DR: Multimodel inference: Understanding AIC and BIC in model selection. Sociol. Methods Res 2004, 33:261-304. (Pubitemid 39519124)
62. Efron B, Tibshirani R: Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat. Sci 1986, 1:77-97.